Guy Helman

CONSORT 2010 statement: extension to randomised pilot and feasibility trials

Clinical, clinicopathologic, radiographic, and ultrasonographic characteristics of intestinal lymphangiectasia in dogs: 17 cases (1996–1998)

Effect of Tissue Processing on Assessment of Endoscopic Intestinal Biopsies in Dogs and Cats

Histopathological Standards for the Diagnosis of Gastrointestinal Inflammation in Endoscopic Biopsy Samples from the Dog and Cat: A Report from the World Small Animal Veterinary Association Gastrointestinal Standardization Group

Sphingolipids and their metabolism in physiology and disease

Ageing as a risk factor for neurodegenerative disease

Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP

mTOR at the nexus of nutrition, growth, ageing and disease

Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework

Cockayne syndrome: Clinical features, model systems and pathways

Endoscopic, Biopsy, and Histopathologic Guidelines for the Evaluation of Gastrointestinal Inflammation in Companion Animals

Constitutive activation of mTORC1 signaling induced by biallelic loss-of-function mutations in SZT2 underlies a discernible neurodevelopmental disease

Deficiency of the alkaline ceramidase ACER3 manifests in early childhood by progressive leukodystrophy

Accurate proteome-wide missense variant effect prediction with AlphaMissense

Intestinal Crypt Lesions Associated with Protein-Losing Enteropathy in the Dog

Case definition and classification of leukodystrophies and leukoencephalopathies

A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies

Intestinal Crypt Lesions Associated with Protein‐Losing Enteropathy in the Dog

Neuroradiologic patterns and novel imaging findings in Aicardi-Goutières syndrome

Mutations in SZT2 result in early‐onset epileptic encephalopathy and leukoencephalopathy